Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)

Alice T.W. Song; Vanderson Rocha; Alfredo Mendrone-Júnior; Rodrigo T. Calado; Gil C. De Santis; Bruno D. Benites; Carolina Costa-Lima; Taiani Vargas; Leonardo S. Marques; Juliana C. Fernandes; Felipe C. Breda; Silvano Wendel; Roberta Fachini; Luiz V. Rizzo; José Mauro Kutner; Vivian I. Avelino-Silva; Rafael R.G. Machado; Edison L. Durigon; Sylvie Chevret; Esper G. Kallas

The Lancet Regional Health - Americas (2022) - Comments
pubmed: 35308034 doi: 10.1016/j.lana.2022.100216 issn: 2667-193x

Alice T.W. Song, Vanderson Rocha, Alfredo Mendrone-Júnior, Rodrigo T. Calado, Gil C. De Santis, Bruno D. Benites, Carolina Costa-Lima, Taiani Vargas, Leonardo S. Marques, Juliana C. Fernandes, Felipe C. Breda, Silvano Wendel, Roberta Fachini, Luiz V. Rizzo, José Mauro Kutner, Vivian I. Avelino-Silva, Rafael R.G. Machado, Edison L. Durigon, Sylvie Chevret, Esper G. Kallas